Government Agencies – Page 3 – Policy & Medicine

Industry Seeks Clarity on Interchangeability for BsUFA III

FDA Issues Draft Guidance on Proprietary Names

CDRH Releases List of FY 2021 Priority Guidance Documents

HHS Issues Policy Statements and RFI on Rulemaking and Transparency

Bausch Health (FKA Valeant Pharmaceuticals) Agrees to $45 Million SEC Settlement

CMS Releases Proposed Rule to Encourage Value-Based Arrangements

HHS Final Rule a Win for Copay Accumulator Adjustment Programs

DEA Amends Regulations Applicable to Registrants Ordering Certain Controlled Substances

OPDP to Study Physicians’ Interpretations of Drug Information

Three Pharma Companies Sue HHS, Judge Rules in Their Favor